Profile: George King Bio-Medical, Inc. supplies clinical hemostasis products. We have obtained the CE certification. Our product range includes coagulation factor deficient plasmas, coagulation control plasmas, plasma sets and specialty plasmas. Our coagulation factor deficient plasmas are from human donors with congenital deficiencies. Our factor deficient plasmas include factor I, II, V, VII, VIII, IX, X, XI, XII & XIII deficient plasmas, von Willebrand Trait plasmas, Prekallikrein deficient plasma and Kininogen deficient plasma. Our coagulation control plasmas include FACT, B-FACT & A-FACT factor assay control plasmas, pooled normal plasma (PNP), Coumadin® plasma and positive lupus anticoagulant. Our plasma sets include multi-coumadin set, control of range evaluation set (CORE set), systems correlation set (SysCOR set) and proficiency sample set. EVALU-VIII is a set of five assayed plasmas with varying levels of Factor VIII activity. Plasmas may not be monospecific and should be used only as FVIII controls. Plasmas in this set are tested and found non-reactive for HIV and HBsAg. Protein C Deficient Plasma is a pooled normal plasma adsorbed with monoclonal antibody to Protein C to prepare the depleted plasma. This plasma is tested and found non-reactive for HIV, HCV and HBsAg. The Multi-Coumadin® Set includes 5 x 1 ml vials each of five different plasmas with varied INR values. This set of plasmas may be used for a variety of applications in the coagulation and thrombosis laboratory. Plasmas in this set are tested and found non-reactive for HIV, HCV & HBsAg.

The company was founded in 1973, has ~20 employees. TSE:SRLSE (SEC Filings)

FDA Registration Number: 1928890